Urea

Radiodermatitis

University of BrasiliaSmall moleculePhase 3Dormant

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 56/ 100
Competitive Position: 95/ 100

Competitive context

12 Active assets in the Radiodermatitis cohort.

Asset / Sponsor	Phase	Rating
BETAMETHASONE Cairo University	Phase 4	BB
Olea europaea oil Cairo University	Phase 4	BB
Chamomilla recutita University of Brasilia	Phase 3	BB
Mometasone North Central Cancer Treatment Group	Phase 3	BB
Cicaderma Centre Leon Berard	Phase 3	B

View all 33 →

Same molecule, other indications

Urea is also rated in:

hepatocellular carcinomaDormant

B

Indicative ·

63 / 100

cancer of unknown primary siteDormant

B

Indicative ·

62 / 100

kidney benign neoplasmDormant

CCC

Indicative ·

53 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.